Development of a computerized adverse drug event monitor.

Adverse events during drug therapy are receiving renewed attention. Some adverse drug events (ADEs) are identified only after the widespread clinical use of a drug. The Food and Drug Administration advocates post-marketing surveillance systems to provide early warnings of previously undetected ADEs....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Evans, R. S., Pestotnik, S. L., Classen, D. C., Bass, S. B., Menlove, R. L., Gardner, R. M., Burke, J. P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Medical Informatics Association 1991
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2247488/
https://ncbi.nlm.nih.gov/pubmed/1807594
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak